Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jamshid Hadjati

Increased Efficacy of a Dendritic Cell–based Therapeutic Cancer Vaccine With Adenosine Receptor Antagonist and CD73 Inhibitor

Tumor Biology

Medicine

Cancer Research

2017

English

Anti-Regulatory T Cell Vaccines in Immunotherapy: Focusing on FoxP3 as Target

Human Vaccines and Immunotherapeutics

English

Related publications

Pleurotus Ferulae Polysaccharides Improve the Antitumor Efficacy of Therapeutic Human Papillomavirus Dendritic Cell-Based Vaccine

Human Vaccines and Immunotherapeutics

English

Clinical Responses in Patients With Advanced Colorectal Cancer to a Dendritic Cell Based Vaccine

English

Microenvironmental Derived Factors Modulating Dendritic Cell Function and Vaccine Efficacy: The Effect of Prostanoid Receptor and Nuclear Receptor Ligands

Cancer Immunology, Immunotherapy

English

High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes

Frontiers in Oncology

Cancer Research

Oncology

2018

English

Improving Therapeutic HPV Peptide-Based Vaccine Potency by Enhancing CD4+ T Help and Dendritic Cell Activation

Journal of Biomedical Science

Clinical Biochemistry

English

Therapeutic MUC1-Based Cancer Vaccine Expressed in Flagella-Efficacy in an Aggressive Model of Breast Cancer

World Journal of Vaccines

2012

English

Immunotherapy of Cancer With Dendritic Cell-Based Vaccines

English

Systemic Administration of Interleukin 2 Enhances the Therapeutic Efficacy of Dendritic Cell-Based Tumor Vaccines

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1999

English

Targeting the Adenosine 2A Receptor Enhances Chimeric Antigen Receptor T Cell Efficacy

Journal of Clinical Investigation

Medicine

2017

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jamshid Hadjati

Increased Efficacy of a Dendritic Cell–based Therapeutic Cancer Vaccine With Adenosine Receptor Antagonist and CD73 Inhibitor

Anti-Regulatory T Cell Vaccines in Immunotherapy: Focusing on FoxP3 as Target

Related publications

Pleurotus Ferulae Polysaccharides Improve the Antitumor Efficacy of Therapeutic Human Papillomavirus Dendritic Cell-Based Vaccine

Clinical Responses in Patients With Advanced Colorectal Cancer to a Dendritic Cell Based Vaccine

Microenvironmental Derived Factors Modulating Dendritic Cell Function and Vaccine Efficacy: The Effect of Prostanoid Receptor and Nuclear Receptor Ligands

High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes

Improving Therapeutic HPV Peptide-Based Vaccine Potency by Enhancing CD4+ T Help and Dendritic Cell Activation

Therapeutic MUC1-Based Cancer Vaccine Expressed in Flagella-Efficacy in an Aggressive Model of Breast Cancer

Immunotherapy of Cancer With Dendritic Cell-Based Vaccines

Systemic Administration of Interleukin 2 Enhances the Therapeutic Efficacy of Dendritic Cell-Based Tumor Vaccines

Targeting the Adenosine 2A Receptor Enhances Chimeric Antigen Receptor T Cell Efficacy